Global Intravenous Equipment Market Size By Type (Infusion Pump, Catheter), By Application (Hospitals And Clinics, Homecare), By Region, And Segment Forecasts, 2023 to 2032

The Global Intravenous (IV) Equipment Market was valued at USD 13.6 billion in 2023 and is projected to reach USD 23.4 billion by 2031, growing at a CAGR of 7.0% during the forecast period from 2023 to 2031. The market is witnessing robust growth due to increasing hospital admissions, rising prevalence of chronic and infectious diseases, and the expansion of outpatient and home healthcare services. Technological advancements in IV equipment—such as smart infusion pumps and needle-free connectors—are also enhancing safety, efficiency, and patient outcomes, thereby fueling market demand.

Drivers:

1. Rising Incidence of Chronic Diseases:

The growing burden of conditions such as cancer, diabetes, and cardiovascular diseases is driving demand for intravenous drug administration for long-term care and continuous therapy.

2. Technological Advancements:

Innovations like wireless infusion pumps, integrated drug libraries, and alarms for infiltration detection are enhancing precision and reducing errors, fostering adoption across healthcare settings.

3. Growing Geriatric Population:

The aging population is more prone to chronic conditions, surgeries, and the need for long-term hospitalization, thereby increasing the demand for IV therapy.

Restraints:

1. High Cost of Advanced Equipment:

The adoption of advanced IV technologies like smart pumps can impose high costs on healthcare providers, especially in low- and middle-income countries.

2. Risks of Infections and Complications:

IV therapy is associated with complications such as catheter-related bloodstream infections and infiltration, which can deter usage and necessitate stringent handling protocols.

Opportunity:

1. Rising Demand for Home Healthcare Services:

The shift toward home-based care, particularly for chronic illness management and palliative care, is creating significant opportunities for portable and user-friendly IV equipment.

2. Healthcare Infrastructure Expansion in Emerging Economies:

Countries in Asia-Pacific and Latin America are heavily investing in healthcare infrastructure, increasing access to quality IV equipment.

Market by System Type Insights:

By system type, the IV Infusion Pumps segment held the largest share in 2023. These pumps offer enhanced control over drug dosage and flow rate, making them essential for critical care and high-risk patients. The Catheters & Cannulas segment is also growing rapidly, driven by rising surgical procedures and emergency care requirements.

Market by End-use Insights:

Hospitals dominated the market in 2023, accounting for over 45% of the total share, due to high patient volumes and the need for intensive care. The Home Healthcare segment is expected to witness the fastest growth, driven by the need for cost-effective care and the availability of portable infusion systems.

Market by Regional Insights:

North America led the global intravenous equipment market in 2023, owing to a well-established healthcare system, high adoption of advanced technologies, and rising chronic disease prevalence. Asia-Pacific is anticipated to register the highest growth during the forecast period, supported by increasing healthcare investments and patient awareness in countries such as India and China.

Competitive Scenario:

Key players in the global IV equipment market include Baxter International Inc., B. Braun Melsungen AG, ICU Medical Inc., Fresenius Kabi AG, Smiths Medical, Terumo Corporation, BD (Becton, Dickinson and Company), Nipro Corporation, Moog Inc., and Vygon Group. These companies are focusing on product innovation, regulatory approvals, and strategic mergers & acquisitions.

Key Market Developments:

In 2023, Baxter launched a new generation of infusion pumps with wireless connectivity and real-time patient monitoring.

In 2024, ICU Medical acquired a major catheter manufacturer to strengthen its presence in vascular access solutions.

In 2025, BD announced FDA clearance for a next-gen IV catheter with integrated safety features to reduce infection risks.

Scope of Work – Global Intravenous Equipment Market

Report Metric Details

Market Size (2023) USD 13.6 billion

Projected Market Size (2031) USD 23.4 billion

CAGR (2023–2031) 7.0%

Market Segments By System Type (Infusion Pumps, Catheters, etc.), End-Use (Hospitals, Homecare), Region

Growth Drivers Rising chronic disease prevalence, aging population, technological advancements

Opportunities Home healthcare growth, emerging market healthcare expansion

FAQs

1. What is the current market size of the Global Intravenous Equipment Market?

The market was valued at USD 13.6 billion in 2023.

2. What is the major growth driver of the Global Intravenous Equipment Market?

The major growth driver is the rising prevalence of chronic diseases and increasing demand for advanced IV therapy technologies.

3. Which is the largest region during the forecast period in the Global Intravenous Equipment Market?

North America is expected to remain the largest regional market.

4. Which segment accounted for the largest market share in the Global Intravenous Equipment Market?

The IV Infusion Pumps segment accounted for the largest share in 2023.

5. Who are the key market players in the Global Intravenous Equipment Market?

Key players include Baxter, B. Braun, ICU Medical, BD, Fresenius Kabi, and Smiths Medical.